You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-MAP2 antibody [HM-2] - Neuronal Marker (ab11267)

CodeSizePriceAbpointsAvailability
    
 
  • -

  •   
  •   
  •   
  •  

  •  
  •  
  •  

  •  
Updating...

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »

Publishing research using ab11267? Please let us know so that we can cite the reference in this datasheet

Show applications key

ab11267 has been referenced in 16 publications.

  1. Bailey JA et al. Rivastigmine Lowers Aß and Increases sAPPa Levels, Which Parallel Elevated Synaptic Markers and Metabolic Activity in Degenerating Primary Rat Neurons. PLoS One 6:e21954 (2011). ICC/IF; Rat. PubMed: 21799757
  2. Carvalho AF et al. Cannabinoid modulation of limbic forebrain noradrenergic circuitry. Eur J Neurosci : (2010). IHC (PFA fixed); Rat. PubMed: 20074224
  3. Orlova KA et al. STRADalpha deficiency results in aberrant mTORC1 signaling during corticogenesis in humans and mice. J Clin Invest 120:1591-602 (2010). IHC-FoFr; Mouse. PubMed: 20424326
  4. Riegelsberger UM et al. Intravenous human umbilical cord blood transplantation for stroke: Impact on infarct volume and caspase-3-dependent cell death in spontaneously hypertensive rats. Exp Neurol : (2010). IHC-FoFr; Rat. PubMed: 21087606
  5. Regad T et al. The tumor suppressor Pml regulates cell fate in the developing neocortex. Nat Neurosci 12:132-40 (2009). ICC/IF, IHC-P; Mouse. PubMed: 19136970
  6. Zhao Y et al. The varying effects of short-term and long-term corticosterone injections on depression-like behavior in mice. Brain Res : (2009). WB; Mouse. PubMed: 19401166
  7. Shi M et al. Identification of glutathione S-transferase pi as a protein involved in Parkinson disease progression. Am J Pathol 175:54-65 (2009). IHC-P; Human. PubMed: 19498008
  8. Herrero-Mendez A et al. The bioenergetic and antioxidant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC/C-Cdh1. Nat Cell Biol 11:747-52 (2009). WB; Rat. PubMed: 19448625
  9. Fu L et al. Derivation of neural stem cells from mesenchymal stemcells: evidence for a bipotential stem cell population. Stem Cells Dev 17:1109-21 (2008). ICC/IF; Human. PubMed: 18426339
  10. Regad T et al. The neural progenitor-specifying activity of FoxG1 is antagonistically regulated by CKI and FGF. Nat Cell Biol 9:531-40 (2007). IHC-P; Mouse. PubMed: 17435750
  11. Yu Y et al. Combination of bFGF, heparin and laminin induce the generation of dopaminergic neurons from rat neural stem cells both in vitro and in vivo. J Neurol Sci 255:81-6 (2007). PubMed: 17360004
  12. Jones SC et al. Stroke onset time using sodium MRI in rat focal cerebral ischemia. Stroke 37:883-8 (2006). PubMed: 16424376
  13. Bergsland M et al. The establishment of neuronal properties is controlled by Sox4 and Sox11. Genes Dev 20:3475-86 (2006). PubMed: 17182872
  14. Odeberg J et al. Human cytomegalovirus inhibits neuronal differentiation and induces apoptosis in human neural precursor cells. J Virol 80:8929-39 (2006). ICC/IF; Human. PubMed: 16940505
  15. O'Hare MJ et al. Differential roles of nuclear and cytoplasmic cyclin-dependent kinase 5 in apoptotic and excitotoxic neuronal death. J Neurosci 25:8954-66 (2005). PubMed: 16192386
  16. Farah CA et al. Interaction of microtubule-associated protein-2 and p63: a new link between microtubules and rough endoplasmic reticulum membranes in neurons. J Biol Chem 280:9439-49 (2005). PubMed: 15623521

Publishing research using ab11267? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"